188 related articles for article (PubMed ID: 32163919)
1. GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours.
Paulsson JO; Wang N; Gao J; Stenman A; Zedenius J; Mu N; Lui WO; Larsson C; Juhlin CC
Endocr Relat Cancer; 2020 May; 27(5):295-308. PubMed ID: 32163919
[TBL] [Abstract][Full Text] [Related]
2. GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
Yuan X; Mu N; Wang N; Strååt K; Sofiadis A; Guo Y; Stenman A; Li K; Cheng G; Zhang L; Kong F; Ekblad L; Wennerberg J; Nilsson IL; Juhlin CC; Larsson C; Xu D
Oncogene; 2019 Feb; 38(7):965-979. PubMed ID: 30181547
[TBL] [Abstract][Full Text] [Related]
3. Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a Somatic DICER1 Gene Mutation: Case Report and Review of the Literature.
Hellgren LS; Hysek M; Jatta K; Zedenius J; Juhlin CC
Head Neck Pathol; 2021 Jun; 15(2):668-675. PubMed ID: 32712880
[TBL] [Abstract][Full Text] [Related]
4. Predominant
Lee YA; Im SW; Jung KC; Chung EJ; Shin CH; Kim JI; Park YJ
Thyroid; 2020 Aug; 30(8):1120-1131. PubMed ID: 32228164
[No Abstract] [Full Text] [Related]
5. Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features.
Juhlin CC; Stenman A; Zedenius J
Histopathology; 2021 Oct; 79(4):661-666. PubMed ID: 34008223
[TBL] [Abstract][Full Text] [Related]
6. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas.
Yegen G; Altay AY; Yılmaz İ; İşcan Y; Sormaz İC; Aksakal N; Önder S; Mete Ö
Endocr Pathol; 2023 Sep; 34(3):279-286. PubMed ID: 37574466
[TBL] [Abstract][Full Text] [Related]
7. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology-histopathology correlation in 7 patients.
Darbinyan A; Morotti R; Cai G; Prasad ML; Christison-Lagay E; Dinauer C; Adeniran AJ
Cancer Cytopathol; 2020 Oct; 128(10):746-756. PubMed ID: 32897650
[TBL] [Abstract][Full Text] [Related]
8. Expanding the spectrum of thyroid carcinoma with somatic DICER1 mutation: a survey of 829 thyroid carcinomas using MSK-IMPACT next-generation sequencing platform.
Ghossein CA; Dogan S; Farhat N; Landa I; Xu B
Virchows Arch; 2022 Feb; 480(2):293-302. PubMed ID: 34580763
[TBL] [Abstract][Full Text] [Related]
9. High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid.
Bae JS; Jung SH; Hirokawa M; Bychkov A; Miyauchi A; Lee S; Chung YJ; Jung CK
Endocr Pathol; 2021 Sep; 32(3):336-346. PubMed ID: 34313965
[TBL] [Abstract][Full Text] [Related]
10. Thyrocyte-specific Dicer1 deficiency alters thyroid follicular organization and prevents goiter development.
Undeutsch H; Löf C; Pakarinen P; Poutanen M; Kero J
Endocrinology; 2015 Apr; 156(4):1590-601. PubMed ID: 25594698
[TBL] [Abstract][Full Text] [Related]
11. Role of Dicer1 in thyroid cell proliferation and differentiation.
Penha RCC; Sepe R; De Martino M; Esposito F; Pellecchia S; Raia M; Del Vecchio L; Decaussin-Petrucci M; De Vita G; Pinto LFR; Fusco A
Cell Cycle; 2017; 16(23):2282-2289. PubMed ID: 28933615
[TBL] [Abstract][Full Text] [Related]
12. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: DICER1-Related Thyroid Tumors.
Sauer M; Barletta JA
Head Neck Pathol; 2022 Mar; 16(1):190-199. PubMed ID: 35307774
[TBL] [Abstract][Full Text] [Related]
13. Macrofollicular Variant of Follicular Thyroid Carcinoma: A Rare Underappreciated Pitfall in the Diagnosis of Thyroid Carcinoma.
Bongiovanni M; Sykiotis GP; La Rosa S; Bisig B; Trimech M; Missiaglia E; Gremaud M; Salvatori Chappuis V; De Vito C; Sciarra A; Foulkes WD; Pusztaszeri M
Thyroid; 2020 Jan; 30(1):72-80. PubMed ID: 31701808
[No Abstract] [Full Text] [Related]
14. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.
Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG
J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159
[TBL] [Abstract][Full Text] [Related]
15.
Ricarte-Filho JC; Casado-Medrano V; Reichenberger E; Spangler Z; Scheerer M; Isaza A; Baran J; Patel T; MacFarland SP; Brodeur GM; Stewart DR; Baloch Z; Bauer AJ; Wasserman JD; Franco AT
Front Endocrinol (Lausanne); 2023; 14():1083382. PubMed ID: 36896180
[TBL] [Abstract][Full Text] [Related]
16. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
[TBL] [Abstract][Full Text] [Related]
17. miR-142-3p down-regulation contributes to thyroid follicular tumorigenesis by targeting ASH1L and MLL1.
Colamaio M; Puca F; Ragozzino E; Gemei M; Decaussin-Petrucci M; Aiello C; Bastos AU; Federico A; Chiappetta G; Del Vecchio L; Torregrossa L; Battista S; Fusco A
J Clin Endocrinol Metab; 2015 Jan; 100(1):E59-69. PubMed ID: 25238203
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis.
Aldred MA; Ginn-Pease ME; Morrison CD; Popkie AP; Gimm O; Hoang-Vu C; Krause U; Dralle H; Jhiang SM; Plass C; Eng C
Cancer Res; 2003 Jun; 63(11):2864-71. PubMed ID: 12782592
[TBL] [Abstract][Full Text] [Related]
19.
Paulsson JO; Mu N; Shabo I; Wang N; Zedenius J; Larsson C; Juhlin CC
Endocr Relat Cancer; 2018 Jul; 25(7):723-733. PubMed ID: 29692346
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinicopathological role of miR146a in thyroid follicular carcinoma.
Pignatti E; Vighi E; Magnani E; Kara E; Roncati L; Maiorana A; Santi D; Madeo B; Cioni K; Carani C; Rochira V; Simoni M; Brigante G
Endocrine; 2019 Jun; 64(3):575-583. PubMed ID: 30701447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]